======= XPNPEP1 =======
== Gene Information ==
* **Official Symbol**: XPNPEP1
* **Official Name**: X-prolyl aminopeptidase 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7511|7511]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9NQW7|Q9NQW7]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=XPNPEP1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20XPNPEP1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/602443|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Contributes to the degradation of bradykinin. Catalyzes the removal of a penultimate prolyl residue from the N-termini of peptides, such as Arg-Pro-Pro.
|Peptidase M24|
|Creatinase N|
|bradykinin catabolic process|
|metalloaminopeptidase activity|
|aminopeptidase activity|
|peptide catabolic process|
|manganese ion binding|
|drug catabolic process|
|drug metabolic process|
|peptide metabolic process|
|cellular amide metabolic process|
|protein homodimerization activity|
|organonitrogen compound catabolic process|
|proteolysis|
|organic substance catabolic process|
|cellular catabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|-1.96|
|[[:results:exp499|LY2090314 0.003μM R08 exp499]]|-1.9|
|[[:results:exp217|Mdivi-1 15μM R05 exp217]]|-1.9|
|[[:results:exp169|BH1 1μM R04 exp169]]|-1.87|
|[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|-1.76|
|[[:results:exp147|Resveratrol 16μM R03 exp147]]|-1.73|
|[[:results:exp103|Taxol 0.004μM R03 exp103]]|-1.71|
|[[:results:exp468|CB-5083 0.4μM R08 exp468]]|1.76|
|[[:results:exp480|ETC-159 50μM R08 exp480]]|1.77|
|[[:results:exp317|Geldanamycin 0.015 to 0.05μM on day4 R07 exp317]]|1.87|
|[[:results:exp452|Azithromycin 100μM R08 exp452]]|1.91|
|[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|1.92|
|[[:results:exp442|Ibrutinib 10μM R08 exp442]]|1.97|
|[[:results:exp116|AICAR 240μM R03 exp116]]|2.02|
|[[:results:exp504|MK2206 4μM R08 exp504]]|2.09|
|[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|2.22|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 17433
* **Expression level (log2 read counts)**: 6.34
{{:chemogenomics:nalm6 dist.png?nolink |}}